Showing results (21-30 of 25) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cancer Research|June 24, 2025
The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2Daniel Zingg, Chi-Chuan Lin, Julia Yemelyanenko, et al.Cancer Research|December 29, 2025
C-terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3Julia Yemelyanenko, Jinhyuk Bhin, Eline van der Burg, et al.The Journal of Experimental Medicine|August 29, 2023
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancerJinhyuk Bhin, Julia Yemelyanenko, Xue Chao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical ModelsDejan Juric, Kyung Song, Radia M Johnson, et al.Nature|August 10, 2022
Truncated FGFR2 is a clinically actionable oncogene in multiple cancersDaniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, et al.Pageof 3